Skip to main content

Peer Review reports

From: Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies

Original Submission
7 May 2018 Submitted Original manuscript
25 May 2018 Reviewed Reviewer Report - Kibum Kim
16 Aug 2018 Reviewed Reviewer Report - Gordon Prescott
21 Sep 2018 Author responded Author comments - Michal Pochopien
Resubmission - Version 2
21 Sep 2018 Submitted Manuscript version 2
30 Nov 2018 Author responded Author comments - Michal Pochopien
Resubmission - Version 3
30 Nov 2018 Submitted Manuscript version 3
Publishing
10 Dec 2018 Editorially accepted
9 Jan 2019 Article published 10.1186/s12913-018-3804-4

You can find further information about peer review here.

Back to article page